» Articles » PMID: 32509077

Differential Expression Profiles of CircRNAs in Human Prostate Cancer Based on Chip and Bioinformatic Analysis

Overview
Specialty Pathology
Date 2020 Jun 9
PMID 32509077
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increasing evidence suggests that circRNAs are involved in the pathogenesis of multiple kinds of cancer. Nevertheless, the differential expression of circRNAs in prostate cancer (PCA) is rarely reported.

Material/method: In our present analyses, circRNAs expression profiles were identified in PCA, based on 5 pairs of PCA and matched non-PCA tissues using circRNA chips.

Results: A number of 749 differential circRNAs were expressed between PCA tumor and paracancerous tissues (Fold Change, FC ≥ 2.0 and < 0.05): 261 were upregulated, whereas 487 were downregulated in PCA tissues. Gene ontology and KEGG pathway analyses indicated that many of the circRNAs are related to carcinogenesis. Circ_0033074 and circ_0016064 both showed changes of maximum magnitude among differentially expressed circRNAs.

Conclusions: Our study detected a relative comprehensive differential map of circRNAs in PCA, which may become novel biomarkers for diagnosis, treatment and follow-up in the future.

Citing Articles

Multiple roles of circular RNAs in prostate cancer: from the biological basis to potential clinical applications.

Zheng X, Song L, Cao C, Sun S Eur J Med Res. 2025; 30(1):140.

PMID: 40016786 PMC: 11866600. DOI: 10.1186/s40001-025-02382-0.


The relevance of circRNAs in serum of patients undergoing prostate biopsy.

Samirae L, Krausewitz P, Alajati A, Kristiansen G, Ritter M, Ellinger J Int J Urol. 2024; 31(5):578-580.

PMID: 38363018 PMC: 11524117. DOI: 10.1111/iju.15414.


The Role of Circular RNAs in Male Infertility and Reproductive Cancers: A Narrative Review.

Derakhshan Z, Bahmanpour S, Alaee S, Fallahi J, Tabei S Iran J Med Sci. 2023; 48(6):527-541.

PMID: 38094281 PMC: 10715113. DOI: 10.30476/IJMS.2022.95302.2661.


SERPINA3: Stimulator or Inhibitor of Pathological Changes.

de Mezer M, Rogalinski J, Przewozny S, Chojnicki M, Niepolski L, Sobieska M Biomedicines. 2023; 11(1).

PMID: 36672665 PMC: 9856089. DOI: 10.3390/biomedicines11010156.


Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.

Chen L, Song Y, Hou T, Li X, Cheng L, Li Y J Exp Clin Cancer Res. 2022; 41(1):194.

PMID: 35659274 PMC: 9166435. DOI: 10.1186/s13046-022-02404-3.


References
1.
Tilki D, Schaeffer E, Evans C . Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen Receptor. Eur Urol Focus. 2017; 2(5):499-505. DOI: 10.1016/j.euf.2016.11.013. View

2.
Intasqui P, Bertolla R, Sadi M . Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives. Expert Rev Proteomics. 2017; 15(1):65-79. DOI: 10.1080/14789450.2018.1417846. View

3.
Zhu T, He Y, Yang J, Fu W, Xu X, Si Y . MYBPH inhibits vascular smooth muscle cell migration and attenuates neointimal hyperplasia in a rat carotid balloon-injury model. Exp Cell Res. 2017; 359(1):154-162. DOI: 10.1016/j.yexcr.2017.07.036. View

4.
Zheng R, Sun K, Zhang S, Zeng H, Zou X, Chen R . [Report of cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi. 2019; 41(1):19-28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.005. View

5.
Memczak S, Papavasileiou P, Peters O, Rajewsky N . Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood. PLoS One. 2015; 10(10):e0141214. PMC: 4617279. DOI: 10.1371/journal.pone.0141214. View